Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT06349564)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06349564 Sponsor: NYU Langone Health Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06349564 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 21 and 65 years old
People who are having a routine screening colonoscopy, or a diagnostic camera examination of the upper digestive tract to investigate acid reflux or stomach discomfort, at NYU Langone Brooklyn Hospital

Who may not be able to join:

People with significant vision problems, such as blindness, that would prevent them from watching videos
People with a history of coronary artery disease (a condition affecting the heart's blood vessels)
People with a history of seizures
People with a history of vertigo (a condition causing dizziness or a spinning sensation)
People with a known allergy to plastic
People classified by their doctor as having moderate to severe health risks related to anaesthesia or medical procedures (confirm with trial site)
People who are currently experiencing active bleeding in their digestive tract, such as black or tarry stools, or visible blood in the stool

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maysaa El Zoghbi, MD, NYU Langone Health

Phone: 216-835-7626

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06349564

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

Trial contact: 216-835-7626

More information: https://clinicaltrials.gov/study/NCT06349564

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 21 and 65 years old
People who are having a routine screening colonoscopy, or a diagnostic camera examination of the upper digestive tract to investigate acid reflux or stomach discomfort, at NYU Langone Brooklyn Hospital

Who may not be able to join:

People with significant vision problems, such as blindness, that would prevent them from watching videos
People with a history of coronary artery disease (a condition affecting the heart's blood vessels)
People with a history of seizures
People with a history of vertigo (a condition causing dizziness or a spinning sensation)
People with a known allergy to plastic
People classified by their doctor as having moderate to severe health risks related to anaesthesia or medical procedures (confirm with trial site)
People who are currently experiencing active bleeding in their digestive tract, such as black or tarry stools, or visible blood in the stool

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

9 December 2024

Est. completion

1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total amount of sedative drugs administered during the procedure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov